EGF and colorectal carcinoma: Addition of biological agents targeting valid molecules involved in CRC progress, such as vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF), to CRC traditional chemotherapies further improves the survival of CRC patients23.